{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:56:49Z","timestamp":1776301009977,"version":"3.50.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Occurrence of invasive fungal infections has gained significant attention during recent times in patients with COVID-19. Patients with severe form of COVID-19, such as those treated in the intensive care unit with prolonged steroid use, are particularly vulnerable to secondary bacterial and fungal infections. Disseminated systemic mycosis is a life-threatening condition, especially in immunocompromised patients. Here, we report a case of a recovered severe COVID-19 patient, who presented with persistent fever. <jats:sup>18<\/jats:sup>F-FDG\u2013labeled leukocyte scan revealed focal accumulation of radiotracer in the small intestine and right lung lower lobe. Subsequently, performed biopsy revealed mucormycosis.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003852","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T19:02:09Z","timestamp":1627498929000},"page":"e177-e179","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Invasive Fungal Infection in COVID-19\u2013Recovered Patient Detected on 18F-FDG\u2013Labeled Leukocytes PET\/CT Scan"],"prefix":"10.1097","volume":"47","author":[{"given":"Divya","family":"Manda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishita","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parul","family":"Thakral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subha Shankar","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virupakshappa","family":"CB","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharmender","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"key":"bib1-20250621","first-page":"e416","article-title":"Infectious disease transmission in solid organ transplantation: donor evaluation, recipient risk, and outcomes of transmission","volume":"5","year":"2018","journal-title":"Transplant Direct"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12879-017-2381-1","article-title":"Mucormycosis in renal transplant recipients: review of 174 reported cases","volume":"17","year":"2017","journal-title":"BMC Infect Dis"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/diagnostics11010137","article-title":"The added value of [18F] FDG PET\/CT in the management of invasive fungal infections","volume":"11","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2967\/jnumed.114.137232","article-title":"PET\/CT with 18F-FDG-labeled autologous leukocytes for the diagnosis of infected fluid collections in acute pancreatitis","volume":"55","year":"2014","journal-title":"J Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0883-2897(92)90006-K","article-title":"The use of 2-[18F] fluoro-2-deoxy-d-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography","volume":"19","year":"1992","journal-title":"Int J Rad Appl Instrum B"},{"key":"bib7-20250621","first-page":"625","article-title":"Imaging infection with 18F-FDG-labeled leukocyte PET\/CT: initial experience in 21 patients","volume":"47","year":"2006","journal-title":"J Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-1-59745-204-5_21","article-title":"Fungal and bacterial killing by neutrophils","volume":"470","year":"2009","journal-title":"Methods Mol Biol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:07:27Z","timestamp":1750536447000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003852","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,28]]}}}